Skip to NavigationSkip to content

Avara Avlon falls into administration putting 270 Bristol jobs at risk

Published on 21/02/19 at 09:45am

Bristol-based pharma firm Avara Avlon Pharmaceuticals has fallen into administration putting the jobs of all 270 of its staff at risk.

The contract development and manufacturing organisation (CDMO) is hoping to sell facilities in Avonmouth a suburb of Bristol, which it bought from AstraZeneca in 2016.

David Rubin, of insolvency partners David Rubin and Partners, who are overseeing the administration process, commented: “Avlon has experienced financial difficulties in recent months as a result of a major contract with a customer coming to an end. The Joint Administrators are now managing the site, whilst they seek a buyer for the business and assets.”

“The main issues here are keeping the site operational and ensuring that all health, safety and environment obligations are complied with.”

“We are working closely with the highly professional and experienced workforce to do everything we can to obtain the best outcome for all stakeholders.”

“We have already secured an agreement with the major customer that gives the business immediate short-term funding and means that we do not immediately have to consider mass redundancies.”

The site had previously been earmarked for closure in 2016, after the expiry of a number of AstraZeneca’s patents.

However the 210 employees were saved from redundancy through the deal with Avara. The deal sw Avara manufacture API’s for AstraZeneca on a contract basis.

Louis Goss

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches